{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:05:47Z","timestamp":1781917547226,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Science and Technology Development Fund (STDF), Egypt","award":["1611"],"award-info":[{"award-number":["1611"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.vaccine.2018.02.103","type":"journal-article","created":{"date-parts":[[2018,3,11]],"date-time":"2018-03-11T01:06:51Z","timestamp":1520730411000},"page":"2005-2011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy"],"prefix":"10.1016","volume":"36","author":[{"given":"Iman I.","family":"Salama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia M.","family":"Sami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab N.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somaia I.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanaa M.","family":"Rabah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada A.","family":"Abdel-Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia M.","family":"Elmosalami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan M.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida M.","family":"Abdel Mohsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammal M.","family":"Metwally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal I.","family":"Hassanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa M.","family":"Emam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia A.","family":"Hemida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safaa M.","family":"Elserougy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma A.","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa A.","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Mohsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal H.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.02.103_b0005","unstructured":"World Health Organization, Global Hepatitis Report; 2017 Available at: http:\/\/www.who.int\/hepatitis\/publications\/global-hepatitis-report2017\/en\/ [Accessed 5 November 2017]."},{"key":"10.1016\/j.vaccine.2018.02.103_b0010","unstructured":"Egypt Health Issues Survey. Ministry of Health and population Cairo Egypt. El-Zanaty and associates Cairo Egypt. The Dhs Program ICF International, Rockville, Maryland, USA; 2015. Available at: https:\/\/dhsprogram.com\/pubs\/pdf\/FR302\/FR302.pdf [Accessed 9 June 2017]."},{"key":"10.1016\/j.vaccine.2018.02.103_b0015","unstructured":"World Health Organization, Global Programme for Vaccines and Immunization, Strategic Plan 1998\u20132001 Available at: http:\/\/www.who.int\/iris\/handle\/10665\/65204 [Accessed 12 November 2017]."},{"key":"10.1016\/j.vaccine.2018.02.103_b0020","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/bmj.314.7086.1033","article-title":"Integration of hepatitis B vaccination into national immunization programmes","volume":"314","author":"Van Damme","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2018.02.103_b0025","first-page":"369","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Weekly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2018.02.103_b0030","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1016\/S0264-410X(01)00019-6","article-title":"Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine","volume":"19","author":"Watson","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.103_b0035","doi-asserted-by":"crossref","unstructured":"Gilca V, De Serres G, Boulianne N, De Wals P, Murphy D, Trudeau G et al. Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine. Human Vaccines 6:1, 212\u2013218; February 2010; \u00a9 2010 Landes Bioscience.","DOI":"10.4161\/hv.6.2.10299"},{"key":"10.1016\/j.vaccine.2018.02.103_b0040","unstructured":"Plotkin SA, Orenstein WA, Offit PA. Vaccines. 5th ed. A.P.a.W.A.O. Stanley. Philadelphia: Saunders Elsevier; 2008. p. 1725."},{"key":"10.1016\/j.vaccine.2018.02.103_b0045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(99)07239-6","article-title":"Consensus statement: are booster immunizations needed for lifelong hepatitis B immunity?","volume":"355","author":"European, Consensus Group","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.02.103_b0050","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jhep.2007.01.022","article-title":"Ethnicity, substance use, and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination","volume":"46","author":"Wang","year":"2007","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.vaccine.2018.02.103_b0055","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.4254\/wjh.v7.i12.1660","article-title":"Induced immunity against hepatitis B virus","volume":"7","author":"Said","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.vaccine.2018.02.103_b0060","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/01.inf.0000130952.96259.fd","article-title":"Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth","volume":"23","author":"Petersen","year":"2004","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.vaccine.2018.02.103_b0065","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.1016\/j.vaccine.2007.09.013","article-title":"Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination","volume":"25","author":"Su","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.103_b0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/jiv748","article-title":"Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose","volume":"214","author":"Bruce","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.103_b0075","unstructured":"Mansour E, Abdul-Rahim S, Batouty G, Zaghloul I, Abdel-Hadi S. Integration of hepatitis B immunization in the Expanded Programon Immunization of the Child Survival Project. J Egypt Public Health Assoc 1993; 68:487\u2013494 [PMID: 7775876]"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.103_b0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/cid\/cir270","article-title":"Hepatitis B and the need for a booster dose","volume":"53","author":"Leuridan","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.103_b0085","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1423-0410.2008.01023.x","article-title":"An international collaborative study to establish the 2nd World Health Organization International Standard for hepatitis B virus DNA nucleic acid amplification technology-based assays","volume":"94","author":"Baylis","year":"2008","journal-title":"Vox Sang"},{"key":"10.1016\/j.vaccine.2018.02.103_b0090","doi-asserted-by":"crossref","unstructured":"Chen YS, Chu CH, Wang JH, Lin JS, Chang YC. Predictors of booster response to hepatitis B vaccine at 15 years of age: a cross-sectional school-based study. Pediatr Neonatol 2016:57;302e309.","DOI":"10.1016\/j.pedneo.2015.09.006"},{"key":"10.1016\/j.vaccine.2018.02.103_b0095","unstructured":"Ghalli I, Salah N, Hussein F, Erfan M, El Ruby M, Mazen I et al. Egyptian growth curves for infants, children and adolescents.Crecerenelmondo. In: Satorio A, Buckler JMH, Marazzi N., editors. Italy: Ferring Publisher; 2008."},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2018.02.103_b0100","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1542\/peds.2007-2329C","article-title":"Expert committee recommendations regarding the prevention, assessment and treatment of child and adolescent overweight and obesity: summary report","volume":"120","author":"Barlow","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2018.02.103_b0105","unstructured":"Centers for Disease Control and Prevention (CDC).About BMI for children and teens. 2011; Available at: http:\/\/www.cdc.gov\/healthyweight\/assessing\/bmi\/childrens_bmi\/about_childrens [Accessed 20 September 2017]."},{"key":"10.1016\/j.vaccine.2018.02.103_b0110","doi-asserted-by":"crossref","unstructured":"Zanetti A, Parlato A, Roman\u00f2 L, Desole MG, Ferrera G, Giurdanella F et al. Challenge with a hepatitis B vaccine in two cohorts of 4\u20137-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy. Vaccine 2012; 30: 5770-5775 [PMID: 22789511] http:\/\/doi.org\/10.1016\/j.vaccine.2012.06.078.","DOI":"10.1016\/j.vaccine.2012.06.078"},{"issue":"8","key":"10.1016\/j.vaccine.2018.02.103_b0115","doi-asserted-by":"crossref","first-page":"e753","DOI":"10.1371\/journal.pone.0000753","article-title":"Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence","volume":"2","author":"van der Sande","year":"2007","journal-title":"PLoS One."},{"key":"10.1016\/j.vaccine.2018.02.103_b0120","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0168-8278(03)00152-1","article-title":"Hepatitis B vaccines","volume":"39","author":"Shouval","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2018.02.103_b0125","unstructured":"World Health Organization. Media Center. Hepatitis B fact sheet; 2017 Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/ [Accessed 9 January 2018]."},{"key":"10.1016\/j.vaccine.2018.02.103_b0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.inf.0000050463.28917.25","article-title":"Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination","volume":"22","author":"Williams","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.02.103_b0135","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1016\/j.vaccine.2007.06.059","article-title":"Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years","volume":"25","author":"Hammitt","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.103_b0140","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1086\/587695","article-title":"Humoral and cellular immune responses to a hepatitis B vaccine booster 15\u201318 years after neonatal immunization","volume":"197","author":"Lu","year":"2008","journal-title":"JID"},{"key":"10.1016\/j.vaccine.2018.02.103_b0145","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/j.vaccine.2014.06.070","article-title":"Lasting immune memory against hepatitis B following challenge 10\u201311 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV\/Hib or monovalent hepatitis B vaccine at 3, 5 and 11\u201312 months of age","volume":"33","author":"Avdicova","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.103_b0150","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.vaccine.2009.01.027","article-title":"Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan","volume":"27","author":"Kao","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.103_b0155","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1186\/1471-2458-14-991","article-title":"Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study","volume":"14","author":"Chang","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2018.02.103_b0160","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1016\/j.vaccine.2007.07.022","article-title":"Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago","volume":"25","author":"Wang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.103_b0165","first-page":"100","article-title":"A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines","volume":"8","author":"Giambi","year":"2008","journal-title":"Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.103_b0170","doi-asserted-by":"crossref","unstructured":"Samandari T, Fiore AE, Negus S, Williams JL, Kuhnert W, McMahon BJ et al. Differences in response to a hepatitis b vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics 2007; 120; e373\u2013e381; originally published online Jul 16, 2007.","DOI":"10.1542\/peds.2007-0131"},{"issue":"21","key":"10.1016\/j.vaccine.2018.02.103_b0175","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.vaccine.2012.12.012","article-title":"Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review","volume":"31","author":"Schillie","year":"2013","journal-title":"Vaccine."},{"issue":"12","key":"10.1016\/j.vaccine.2018.02.103_b0180","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00431-012-1815-4","article-title":"Persistence of protection of hepatitis B vaccine and response to booster immunization in 2- to12-year-old children","volume":"171","author":"Aypak","year":"2012","journal-title":"Eur J Pediatr"},{"issue":"11","key":"10.1016\/j.vaccine.2018.02.103_b0185","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S1473-3099(10)70195-X","article-title":"Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study","volume":"10","author":"Zanetti","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.103_b0190","first-page":"17","article-title":"Persistence of HBV vaccine\u2019s protection and response to hepatitis B booster immunization in 5- to 7-year-old children in the Kohgiloyeh and Boyerahmad Province, Iran","volume":"10","author":"Yazdanpanah","year":"2010","journal-title":"Hepat Mon"},{"issue":"31\u201332","key":"10.1016\/j.vaccine.2018.02.103_b0195","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1016\/S0264-410X(02)00405-X","article-title":"Immunogenicity of hepatitis B vaccines: implications of immune memory","volume":"20","author":"Koff","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.02.103_b0200","doi-asserted-by":"crossref","unstructured":"Zinke M, Kappes R, Kindler K, Paulus-Koschik A, Goering U, Disselhoff J et al. Immune memory to hepatitis B virus in 4\u20139-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV\/Hib vaccine. HumVaccine 2009; 5:592\u2013598.","DOI":"10.4161\/hv.9051"},{"key":"10.1016\/j.vaccine.2018.02.103_b0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2334-10-9","article-title":"Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa-HBV-IPV\/Hib in the first and 2nd year of life","volume":"10","author":"Steiner","year":"2010","journal-title":"BMC Infecti Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.103_b0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jmv.20524","article-title":"Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines","volume":"78","author":"Zuckerman","year":"2006","journal-title":"J Med Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1830313X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1830313X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T17:10:55Z","timestamp":1570900255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1830313X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":42,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0264410X1830313X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.103","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}